INCR (Intercure) Unearned Income


INCR Intercure Ltd INCR
66 GF Score
Price $1.00
GF Value $1.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Intercure Unearned Income?

Unearned Income only applies to banks.

INCR
66GF Score
Intercure Ltd INCR
Unearned Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Intercure (INCR) Overvalued in 2026?

Based on GuruFocus' analysis, Intercure stock appears to be undervalued. The current stock price of $1.00 is trading 21.9% below its estimated GF Value™ of $1.28. GuruFocus considers Intercure to be Modestly Undervalued.

Key valuation signals for INCR:

  • Unearned Income:
  • GF Value™: $1.28 vs. price of $1.00 (21.9% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the INCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intercure Business Description

Other Exchanges INCR:Israel
Address 85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
66GF Score

Get the complete analysis for INCR

Unearned Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$1.28
GF Value